Dual PRMT5 and MAT2A Inhibition Kills MTAP-Deficient Gliomas
In a groundbreaking advancement within the realm of neuro-oncology, researchers have unveiled a compelling synthetic lethality approach targeting MTAP homozygous-deficient ...
In a groundbreaking advancement within the realm of neuro-oncology, researchers have unveiled a compelling synthetic lethality approach targeting MTAP homozygous-deficient ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine